Future Price to Earnings: Aspira Women's Health (AWH)

AWH (Vermillion) - company brandmark

Aspira Women's Health minimizes its environmental footprint through the digitalization of documentation and material recycling. Women's health diagnostics are not subject to cycles or seasonality, maintaining stability thanks to insurance. The implementation of AI and automated dispensers optimizes laboratory analysis. The company's forward P/E ratio helps balance risk and return, with the parameter value equal to 0.00.

AWH - Aspira Women's Health Inc. Market Cap to Projected Earnings over the range 07/04/2022 - 04/26/2025

Analytical breakdowns for Aspira Women's Health

- current price and projected stock value:
- company stock exchange capitalization indicators:
Basic company analysis:AWH Aspira Women's Health Inc.
Brand item of Aspira Women's Health

Forward P/E measures a stock's market value relative to projected earnings, allowing investors to determine the extent of the premium paid for the issuer's future income. By analyzing the expected P/E multiple for Aspira Women's Health (AWH), an investor assesses whether the capitalization of Aspira Women's Health (AWH) is justified given the implementation of AI-driven ovarian cancer diagnostics, where low values confirm an undervaluation of the potential for high-tech testing in women's healthcare.

Competitor analysis for Aspira Women's Health

Forward P/E Multiple A|DGX - Projected Price to Earnings Ratio|Illumina Inc - Projected Price to Earnings|exactsciences.com (EXAS) - Projected Price to Earnings Ratio|RVTY - Future Price to Earnings|Market Cap to Projected Earnings Bio-Rad Laboratories, Inc. BIO|NNNN: Forward P/E Multiple|SHC - Market Cap to Projected Earnings|Future Price to Earnings quidel.com|Projected Price to Earnings Ratio opko.com OPK|Forward P/E Multiple CDNA|Projected Price to Earnings Maravai LifeSciences Holdings, Inc. MRVI|Fulgent Genetics Inc - Projected Price to Earnings|Forward P/E Multiple Standard BioTools Corp LAB|CTKB: Projected Price to Earnings|OSUR - Forward P/E Multiple|XGN: Forward P/E Multiple|MDxHealth - Future Price to Earnings Multiple|LUCD (Lucid Diagnostics Inc.) - Forward P/E Multiple|PRE (Prenetics Global) - Market Cap to Future Earnings Ratio|Forward P/E Multiple IMDX|Market Cap to Future Earnings Ratio TRIB|Future Price to Earnings ProPhase Labs Inc PRPH|Market Cap to Projected Earnings Ainos Inc (AIMD)|CODX - Future Price to Earnings|Projected Price to Earnings Ratio Heart Test Labs|BMRA: Forward P/E Multiple|CDIO - Market Cap to Projected Earnings|Projected Price to Earnings ONCO|Future Price to Earnings VRAX|Forward P/E Multiple BJDX|AXDX (Accelerate Diagnostics, Inc) - Future Price to Earnings Multiple|CENTOGENE, N.V. - Projected Price to Earnings|Future Price to Earnings Multiple ENZ|Future Price to Earnings Multiple fresh2.co (FRES)|GENE (Genetic Technologies Limited) - Price to Future Earnings Ratio|ME: Forward P/E Multiple|Price to Future Earnings Ratio PMD